Replimune (REPL) Shares Outstanding (Diluted) (2020 - 2026)
Powered by 
Analysis
Replimune (REPL) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | 255.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 106.00 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 66.03 Mn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | 398.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | 210.89 Mn |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 115.80 Mn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 138.28 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | 556.90 Mn |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Replimune | 1.45 Bn | 1.45 Bn | - | 96.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 96.86 Mn |
| Mar 31, 2026 | 92.80 Mn |
| Dec 31, 2025 | 92.19 Mn |
| Sep 30, 2025 | 91.92 Mn |
| Jun 30, 2025 | 91.52 Mn |
| Mar 31, 2025 | 80.56 Mn |
| Dec 31, 2024 | 83.50 Mn |
| Sep 30, 2024 | 78.57 Mn |
| Jun 30, 2024 | 69.19 Mn |
| Mar 31, 2024 | 66.57 Mn |
| Dec 31, 2023 | 66.65 Mn |
| Sep 30, 2023 | 66.58 Mn |
| Jun 30, 2023 | 66.37 Mn |
| Mar 31, 2023 | 58.21 Mn |
| Dec 31, 2022 | 57.86 Mn |
| Sep 30, 2022 | 54.77 Mn |
| Jun 30, 2022 | 54.21 Mn |
| Mar 31, 2022 | 52.21 Mn |
| Dec 31, 2021 | 52.32 Mn |
| Sep 30, 2021 | 52.08 Mn |